Comparison of infliximab with adalimumab for the treatment of non-infectious uveitis: a systematic review and meta-analysis
Comparison of infliximab with adalimumab for the treatment of non-infectious uveitis: a systematic review and meta-analysis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Comparison of infliximab with adalimumab for the treatment of non-infectious uveitis: a systematic review and meta-analysis have?
Comparison of infliximab with adalimumab for the treatment of non-infectious uveitis: a systematic review and meta-analysis has 14 citations in the OpenAlex counts ScholarIQ stores.
When was Comparison of infliximab with adalimumab for the treatment of non-infectious uveitis: a systematic review and meta-analysis published?
Comparison of infliximab with adalimumab for the treatment of non-infectious uveitis: a systematic review and meta-analysis has 2023 year in the ScholarIQ index.
What is the open-access status of Comparison of infliximab with adalimumab for the treatment of non-infectious uveitis: a systematic review and meta-analysis?
Comparison of infliximab with adalimumab for the treatment of non-infectious uveitis: a systematic review and meta-analysis has gold oa status in the ScholarIQ index.
What is the DOI of Comparison of infliximab with adalimumab for the treatment of non-infectious uveitis: a systematic review and meta-analysis?
The DOI for Comparison of infliximab with adalimumab for the treatment of non-infectious uveitis: a systematic review and meta-analysis is on the source record.
What is the PMID of Comparison of infliximab with adalimumab for the treatment of non-infectious uveitis: a systematic review and meta-analysis?
The PMID for Comparison of infliximab with adalimumab for the treatment of non-infectious uveitis: a systematic review and meta-analysis is on the source record.
What is the OpenAlex record for Comparison of infliximab with adalimumab for the treatment of non-infectious uveitis: a systematic review and meta-analysis?
The OpenAlex for Comparison of infliximab with adalimumab for the treatment of non-infectious uveitis: a systematic review and meta-analysis is on the source record.